Penserra Capital Management LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1593324
ORINDA, CA
Position in ADPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
5,776
+1891.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $74,548,818 across 15 Diagnostics & Research names. ADPT ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDNT |
RadNet, Inc.
|
1,143,622 | $70,527,168 | |
| 2 | GH |
Guardant Health, Inc.
|
19,575 | $2,936,837 | |
| 3 | NTRA |
Natera, Inc.
|
2,504 | $679,710 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
990 | $188,391 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
119 | $148,194 | |
| 6 | RVTY |
Revvity, Inc.
|
326 | $36,270 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
30 | $15,040 | |
| 8 | DHR |
Danaher Corp /De/
|
57 | $10,857 |
All Filings in ADPT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 23,102 | Shares | Defined | 2026-08-13 | |
| 2020-09-30 | — | 1,158 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||